Document:

Exhibit 10.15 to St. Jude Medical, Inc. Form 10-K for fiscal year ended 12-31-2005

Exhibit 10.15 

ST. JUDE MEDICAL, INC.

AMENDED AND RESTATED 2001 EMPLOYEE STOCK OPTION PLAN

(formerly known as the  Advanced Neuromodulation Systems, Inc.

2001 Employee Stock Option Plan) 

        1.    Purpose
of the Plan.   The purposes of the Plan are (i) to attract and retain the best available personnel for
positions of substantial responsibility, and (ii) to provide incentives to such personnel to promote the success of the
business of St. Jude Medical, Inc. and its subsidiaries. 

        2.    Definitions.   As
used herein, the following definitions shall apply: 

                (a)    “Board” means
the Board of Directors of the Corporation.  

                (b)    “Common
Stock” means the Common Stock, $.10 par value per share, of the Corporation. Except as otherwise provided herein, all Common
Stock issued pursuant to the Plan will have the same rights as all other issued and outstanding shares of Common Stock, including
but not limited to voting rights, the right to dividends, if declared and paid, and the right to pro rata distributions of the
Corporation’s assets in the event of liquidation. 

                (c)    “Committee” means
the committee described in Section 18(a) that administers the Plan. 

                (d)    “Corporation” means
St. Jude Medical, Inc., a Minnesota corporation. 

                (e)    “Date
of Grant” means the date on which an Option is granted pursuant to this Plan or, if the Committee so determines, the date
specified by the Committee as the date the award is to be effective. 

                (f)    “Employee” means
any officer or other key employee of the Corporation or one of its Subsidiaries, including any director who is also an officer or
key employee of the Corporation or one of its Subsidiaries. 

                (g)    “Exchange
Act” means the Securities Exchange Act of 1934, as amended. 

                (h)    “Fair
Market Value” means the closing sale price (or average of the quoted closing bid and asked prices if there is no closing sale
price reported) of the Common Stock on the trading day immediately prior to the date specified as reported by the New York Stock
Exchange or by the principal national stock exchange on which the Common Stock is then listed. If there is no reported price
information for the Common Stock, the Fair Market Value will be determined by the Committee, in its sole discretion. In making
such determination, the Committee may, but shall not be obligated to, commission and rely upon an independent appraisal of the
Common Stock. 

                (i)    “Option” means
a stock option granted pursuant to Section 6 of this Plan. 

                (j)    “Optionee” means
any Employee or Director who receives an Option. 

                (k)    “Participant” means
any Employee who receives an Option. 

                (l)    “Plan” means
the St. Jude Medical, Inc. Amended and Restated 2001 Employee Stock Option Plan (which was formerly known as the Advanced
Neuromodulation Systems, Inc. 2001 Employee Stock Option Plan), as amended from time to time. 

                (m)    “Rule
16b-3” means Rule 16b-3 of the rules and regulations under the Exchange Act, as Rule 16b-3 may be amended from time to time,
and any successor provisions to Rule 16b-3 under the Exchange Act. 

  

                (n)    “Subsidiary” means
any now existing or hereinafter organized or acquired company of which more than fifty percent (50%) of the issued and outstanding
voting stock is owned or controlled directly or indirectly by the Corporation or through one or more Subsidiaries of the
Corporation. 

        3.    Term
of Plan.   The Plan was adopted by the Board of Directors of Advanced Neuromodulation Systems, Inc. effective
as of April 2, 2001. The Plan was assumed by the Corporation pursuant to the terms of the Agreement and Plan of Merger among the
Corporation, Apollo Merger Corp., and Advanced Neuromodulation Systems, Inc., dated as of October 15, 2005 (the “Merger
Agreement”). The Plan was amended pursuant to resolutions adopted by the Board on October 14, 2005 in order to make changes
necessary to reflect the assumption of the Plan by the Corporation. Pursuant to the Merger Agreement, at the Effective Time (as
defined in the Merger Agreement), the then outstanding Options under the Plan were converted into Options to purchase Common
Stock. After the Effective Time, no additional Options will be granted under the Plan. The Plan shall continue in effect so long
as Options granted under the Plan remain outstanding, subject to earlier termination as provided under Section 18(a). 

        4.    Shares
Subject to the Plan.   When the Plan was adopted by the Board of Directors of Advanced Neuromodulation Systems,
Inc. it contained the following provision: “Except as otherwise provided in Section 17 hereof, the aggregate number of
shares of Common Stock issuable upon the exercise of Options pursuant to this Plan shall be 180,000 shares; provided, however,
that on January 1 of each year (commencing on January 1, 2001), the aggregate number of shares of Common Stock then
issuable upon the exercise of Options shall be increased by the same percentage that the total number of issued and outstanding
shares of Common Stock increased from the preceding January 1 to the following December 31 (if such percentage is
positive). For example, if the total number of issued and outstanding shares of Common Stock on January 1, 2001 were
5,000,000, the total number of issued and outstanding shares of the Corporation on December 31, 2001 were 5,500,000, and the
aggregate number of shares of Common Stock then issuable upon the exercise of Options pursuant to this Plan were 180,000, the
aggregate number of shares of Common Stock issuable under the Plan effective January 1, 2002 would be 198,000 (a 10%
increase). Shares issuable upon the exercise of Options may either be authorized but unissued shares or treasury shares. The
Corporation shall, during the term of this Plan, reserve and keep available a number of shares of Common Stock sufficient to
satisfy the requirements of the Plan. If an Option should expire or become unexercisable for any reason without having been
exercised in full, then the shares that were subject thereto shall, unless the Plan shall have terminated, become immediately
available for the grant of additional Options under this Plan, subject to the limitations and adjustments set forth above. In
addition, for purposes of calculating the aggregate number of shares that may be issued under this Plan, only the net shares
issued (including the shares, if any, withheld for tax withholding requirements) shall be counted when shares of Common Stock are
used as full or partial payment for shares issued upon exercise of a Option. Shares tendered by a Participant as payment for
shares issued upon such exercise shall be available for reissuance under the Plan.” 

        5.    Eligibility.   Options
may be granted under Section 6 of the Plan to such Employees of the Corporation or its Subsidiaries as may be determined by the
Committee. Subject to the limitations and qualifications set forth in this Plan, the Committee shall also determine the number of
Options to be granted, the number of shares subject to each Option grant, the exercise price or prices of each Option, the vesting
and exercise period of each Option, whether an Option may be exercised as to less than all of the Common Stock subject thereto,
and such other terms and conditions of each Option as are consistent with the provisions of this Plan. 

        6.    Grant
of Options.   Except as provided in Section 18(c), the Committee shall determine the number of shares of Common
Stock to be offered from time to time pursuant to Options granted hereunder and shall grant Options under the Plan. No member of
the Committee shall be eligible to receive Options. The grant of Options shall be evidenced by Option agreements containing such
terms and provisions as are approved by the Committee and executed on behalf of the Corporation by an appropriate officer.

        7.    Time
of Grant of Options.   The date of grant of an Option under the Plan shall be the date on which the Committee
awards the Option or, if the Committee so determines, the date specified by the Committee as the date the award is to be
effective. Notice of the grant shall be given to each Participant to whom an Option is granted promptly after the date of such
grant. 

2 

        8.    Price.   The
exercise price for each share of Common Stock subject to an Option (the “Exercise Price”) granted pursuant to Section 6
of the Plan shall be determined by the Committee at the Date of Grant. 

        9.    Vesting.   Subject
to Section 11 of this Plan, each Option award under the Plan shall vest or be subject to forfeiture in accordance with the
provisions set forth in the applicable Option agreement. The Committee may, but shall not be required to, permit acceleration of
vesting or termination of forfeiture provisions upon any sale of the Corporation or similar transaction. A Participant’s
Option agreement may contain such additional provisions with respect to vesting as the Committee may specify. 

        10.    Exercise.   A
Participant may pay the Exercise Price of the shares of Common Stock as to which an Option is being exercised by the delivery of
(a) cash, (b) check, (c) at the Corporation’s option, by the delivery of shares of Common Stock having a Fair
Market Value on the date immediately preceding the exercise date equal to the Exercise Price and have been held by the Optionee at
least six (6) months prior to the date of exercise, or (d) at the Corporation’s option, any other consideration that the
Corporation determines is consistent with the Plan’s purpose and applicable law. If the shares to be purchased are covered by
an effective registration statement under the Securities Act of 1933, as amended, any Option granted under the Plan may be
exercised by a broker-dealer acting on behalf of an Optionee if (i) the broker-dealer has received from the Optionee or the
Corporation a fully- and duly-endorsed agreement evidencing such Option, together with instructions signed by the Optionee
requesting the Corporation to deliver the shares of Common Stock subject to such Option to the broker-dealer on behalf of the
Optionee and specifying the account into which such shares should be deposited, (ii) adequate provision has been made with
respect to the payment of any withholding taxes due upon such exercise, and (iii) the broker-dealer and the Optionee have
otherwise complied with Section 220.3(e)(4) of Regulation T, 12 CFR Part 220, or any successor provision. 

        11.    [Reserved.]  

        12.    Option
Financing.   Upon the exercise of any Option granted under the Plan, the Corporation may, but shall not be
required to, make financing available to the Participant for the purchase of shares of Common Stock pursuant to such Option on
such terms as the Board or the Committee may specify. 

        13.    Withholding
of Taxes.   The Committee shall make such provisions and take such steps as it may deem necessary or
appropriate for the withholding of any taxes that the Corporation is required by any law or regulation of any governmental
authority to withhold in connection with any Option including, but not limited to, (a) withholding the issuance of all or any
portion of the shares of Common Stock subject to such Option until the Participant reimburses the Corporation for the amount it is
required to withhold with respect to such taxes, (b) withholding any portion of such issuance in an amount sufficient to
reimburse the Corporation for the amount of taxes it is required to withhold, (c) allowing the Participant to deliver Common
Stock as payment for the amount the Corporation is required to withhold for taxes or (d) taking any other action reasonably
required to satisfy the Corporation’s withholding obligation. 

        14.    Conditions
Upon Issuance of Shares.  

        (a)    The
Corporation shall not be obligated to sell or issue any shares upon the exercise of any Option granted under the Plan unless the
issuance and delivery of shares comply with all provisions of applicable federal and state securities laws and the requirements of
the New York Stock Exchange or any stock exchange upon which shares of the Common Stock may then be listed. 

        (b)    As
a condition to the exercise of an Option, the Corporation may require the person exercising the Option to make such
representations and warranties as may be necessary to assure the availability of an exemption from the registration requirements
of applicable federal and state securities laws. 

        (c)    The
Corporation shall not be liable for refusing to sell or issue any shares covered by any Option if the Corporation cannot obtain
authority from the appropriate regulatory bodies deemed by the Corporation to be necessary to sell or issue such shares in
compliance with all applicable federal and state securities laws and the requirements of the New York Stock Exchange or any stock
exchange upon which shares of the Common Stock may then be listed. In addition, the Corporation shall have no obligation to any
Participant, express or implied, to list, register or otherwise qualify the shares of Common Stock covered by any Option.

3 

        (d)    No
Participant will be, or will be deemed to be, a holder of any Common Stock subject to an Option unless and until such Participant
has exercised his or her Option and paid the purchase price for the subject shares of Common Stock. 

        15.    Restrictions
on Transfer.  

        (a)    Options
issued pursuant to the Plan shall be nontransferable except by will or the laws of descent and distribution, and may only be
exercisable during the Participant’s lifetime only by the Participant. 

        (b)    Shares
of Common Stock issued pursuant to the Plan may be subject to restrictions on transfer under applicable federal and state
securities laws. The Committee may impose such additional restrictions on the ownership and transfer of shares of Common Stock
issued pursuant to the Plan as it deems desirable; any such restrictions shall be set forth in any Option agreement entered into
hereunder. 

        16.    Modification
of Plan and Options.  

        (a)    The
Committee may from time to time and at any time alter, amend, suspend, discontinue or terminate this Plan. 

        (b)    At
any time and from time to time, the Committee may execute an instrument providing for modification, extension or renewal of any
outstanding Option, provided that no such modification, extension or renewal shall impair the Option without the consent of the
holder of the Option or conflict with the provisions of Rule 16b-3 or the New York Stock Exchange or any stock exchange on which
shares of the Common Stock may then be listed. 

        17.    Effect
of Change in Stock Subject to the Plan.   In the event that each of the outstanding shares of Common Stock
(other than shares held by dissenting shareholders) shall be changed into or exchanged for a different number or kind of shares of
stock of the Corporation or of another corporation (whether by reason of merger, consolidation, recapitalization,
reclassification, split-up, combination of shares or otherwise), or in the event a stock split or stock dividend occurs, then the
Corporation may either (a) substitute for each share of Common Stock then subject to Options or available for Options the
number and kind of shares of stock into which each outstanding share of Common Stock (other than shares held by dissenting
shareholders) shall be so changed or exchanged, or the number of shares of Common Stock as is equitably required in the event of a
stock split or stock dividend, together with an appropriate adjustment of the Exercise Price, or (b) cancel all such Options
as of the effective date of any merger, consolidation, recapitalization, reclassification, split-up or combination of shares by
giving written notice to each holder thereof or his personal representatives of its intention to do so and by permitting the
exercise of all such Options, without regard to determinations of periods or installments of exercisability during the thirty (30)
day period immediately preceding such effective date. The Committee may, but shall not be required to, provide additional
anti-dilution protection to a Participant under the terms of the Participant’s Option agreement. 

        18.    Administration.  

        (a)    Notwithstanding
anything to the contrary herein, to the extent necessary to comply with the requirements of Rule 16b-3, the Plan shall be
administered by the Board, or by a committee comprised solely of two or more Non-Employee Directors appointed by the Board (the
group responsible for administering the Plan is referred to as the “Committee”). Options may be granted under Section 6
only by majority agreement of the members of the Committee. Option agreements, in the form as approved by the Committee, and
containing such terms and conditions consistent with the provisions of this Plan as are determined by the Committee, may be
executed on behalf of the Corporation by the Chairman of the Board, the President or any Vice President of the Corporation. The
Committee shall have complete authority to construe, interpret and administer the provisions of this Plan and the provisions of
the Option agreements granted hereunder; to prescribe, amend and rescind rules and regulations pertaining to this Plan; to
suspend, discontinue or terminate this Plan; and to make all other determinations necessary or deemed advisable in the
administration of the Plan. The determinations, interpretations and constructions made by the Committee shall be final and
conclusive. No member of the Committee shall be liable for any action taken, or failed to be taken, made in good faith relating to
the Plan or any award thereunder, and the members of the Committee shall be entitled to indemnification and reimbursement by the
Corporation in respect of any claim, loss, damage or expense (including attorneys’ fees) arising therefrom to the fullest
extent permitted by law. 

4 

        (b)    Members
of the Committee shall be specified by the Board, and if the Committee does not consist of the entire Board, the Committee shall
consist solely of Non-Employee Directors. Non-Employee Directors may not possess an interest in any transaction for which
disclosure is required under Section 404(a) of Regulation S-K under the Exchange Act or be engaged in a business relationship that
must be disclosed under Section 404(a). 

        19.    Continued
Employment Not Presumed.   Nothing in this Plan or any document describing it nor the grant of any Option shall
give any Participant the right to continue in the employment of the Corporation or affect the right of the Corporation to
terminate the employment of any such person with or without cause. 

        20.    [Reserved].  

        21.    Governing
Law.   The Plan shall be governed by and construed in accordance with the laws of State of Minnesota and the
United States, as applicable, without reference to the conflict of laws provisions thereof. 

        22.    Severability
of Provisions.   If any provision of this Plan is determined to be invalid, illegal or unenforceable, such
invalidity, illegality or unenforceability shall not affect the remaining provisions of the Plan, but such invalid, illegal or
unenforceable provision shall be fully severable, and the Plan shall be construed and enforced as if such provision had never been
inserted herein. 

5Exhibit 10.16 to St. Jude Medical, Inc. Form 10-K for fiscal year ended 12-31-2005

Exhibit 10.16 

ST. JUDE MEDICAL, INC.

AMENDED AND RESTATED 2002 STOCK OPTION PLAN

(formerly known as the Advanced Neuromodulation Systems, Inc. 2002 Stock Option Plan) 

        1.    Purpose
of the Plan.   This Plan shall be known as the St. Jude Medical, Inc. Amended and Restated 2002 Stock Option
Plan. The purposes of the Plan are (i) to attract and retain the best available advisory directors, consultants and
non-executive employees, and (ii) to provide incentives to such advisory directors, consultants and non-executive employees
to promote the success of the business of St. Jude Medical, Inc. and its subsidiaries. 

        2.    Definitions.   As
used herein, the following definitions shall apply: 

                (a)    “Advisory
Director” means a person that the Corporation designates as a member of the Corporation’s Advisory Board of Directors.

                (b)    “Board” means
the Board of Directors of the Corporation. 

                (c)    “Common
Stock” means the Common Stock, $.10 par value per share, of the Corporation. Except as otherwise provided herein, all Common
Stock issued pursuant to the Plan shall have the same rights as all other issued and outstanding shares of Common Stock, including
but not limited to voting rights, the right to dividends, if declared and paid, and the right to pro rata distributions of the
Corporation’s assets in the event of liquidation. 

                (d)    “Committee” means
the committee described in Section 18(a) that administers the Plan. 

                (e)    “Consultant” means
a consultant engaged by the Corporation to render consulting services to the Corporation. 

                (f)    “Corporation” means
St. Jude Medical, Inc., a Minnesota corporation. 

                (g)    “Date
of Grant” means the date on which an Option is granted pursuant to this Plan or, if the Committee so determines, the date
specified by the Committee as the date the award is to be effective. 

                (h)    “Employee” means
any employee of the Corporation or one of its Subsidiaries, but excluding any “executive officer” (as defined in Rule
3b-7 promulgated pursuant to the Exchange Act) or director of the Corporation or one of its Subsidiaries. 

                (i)    “Exchange
Act” means the Securities Exchange Act of 1934, as amended. 

                (j)    “Fair
Market Value” means the closing sale price (or average of the quoted closing bid and asked prices if there is no closing sale
price reported) of the Common Stock on the trading day immediately prior to the date specified as reported by the New York Stock
Exchange or by the principal national stock exchange on which the Common Stock is then listed. If there is no reported price
information for the Common Stock, the Fair Market Value will be determined by the Committee, in its sole discretion. In making
such determination, the Committee may, but shall not be obligated to, commission and rely upon an independent appraisal of the
Common Stock. 

                (k)    “Option” means
a stock option granted pursuant to Section 6 of this Plan.. 

                (l)    “Optionee” means
any Employee, Advisory Director, or Consultant who receives an Option. 

                (m)    “Participant” means
any Employee, Advisory Director, or Consultant who receives an Option. 

  

                (n)    “Plan” means
the St. Jude Medical, Inc. Amended and Restated 2002 Stock Option Plan (which was formerly known as the Advanced Neuromodulation
Systems, Inc. 2002 Stock Option Plan), as amended from time to time. 

                (o)    “Rule
16b-3” means Rule 16b-3 of the rules and regulations under the Exchange Act, as Rule 16b-3 may be amended from time to time,
and any successor provisions to Rule 16b-3 under the Exchange Act. 

                (p)    “Subsidiary” means
any now existing or hereinafter organized or acquired company of which more than fifty percent (50%) of the issued and outstanding
voting stock is owned or controlled directly or indirectly by the Corporation or through one or more Subsidiaries of the
Corporation. 

        3.    Term
of Plan.   The Plan was adopted by the Board of Directors of Advanced Neuromodulation Systems, Inc. effective
as of June 5, 2002. The Plan was assumed by the Corporation pursuant to the terms of the Agreement and Plan of Merger among the
Corporation, Apollo Merger Corp., and Advanced Neuromodulation Systems, Inc., dated as of October 15, 2005 (the “Merger
Agreement”). The Plan was amended pursuant to resolutions adopted by the Board on October 14, 2005 in order to make changes
necessary to reflect the assumption of the Plan by the Corporation. Pursuant to the Merger Agreement, at the Effective Time (as
defined in the Merger Agreement), the then outstanding Options under the Plan were converted into Options to purchase Common
Stock. After the Effective Time, no additional Options will be granted under the Plan. The Plan shall continue in effect so long
as Options granted under the Plan remain outstanding, subject to earlier termination as provided under Section 18(a). 

        4.    Shares
Subject to the Plan.   When the Plan was adopted by the Board of Directors of Advanced Neuromodulation Systems,
Inc. it contained the following provision: “Except as otherwise provided in Section 17 hereof, the aggregate number of shares
of Common Stock issuable upon the exercise of Options pursuant to this Plan shall be 225,000 shares; provided, however, that on
January 1 of each year (commencing on January 1, 2003), the aggregate number of shares of Common Stock then issuable upon the
exercise of Options shall be increased by the same percentage that the total number of issued and outstanding shares of Common
Stock increased from the preceding January 1 to the following December 31 (if such percentage is positive). For example, if the
total number of issued and outstanding shares of Common Stock on January 1, 2002 were 5,000,000, the total number of issued and
outstanding shares of the Corporation on December 31, 2002 were 5,500,000, and the aggregate number of shares of Common Stock then
issuable upon the exercise of Options pursuant to this Plan were 180,000, the aggregate number of shares of Common Stock issuable
under the Plan effective January 1, 2003 would be 198,000 (a 10% increase). Shares issuable upon the exercise of Options may
either be authorized but unissued shares or treasury shares. The Corporation shall, during the term of this Plan, reserve and keep
available a number of shares of Common Stock sufficient to satisfy the requirements of the Plan. If an Option should expire or
become unexercisable for any reason without having been exercised in full, then the shares that were subject thereto shall, unless
the Plan shall have terminated, become immediately available for the grant of additional Options under this Plan, subject to the
limitations and adjustments set forth above. In addition, for purposes of calculating the aggregate number of shares that may be
issued under this Plan, only the net shares issued (including the shares, if any, withheld for tax withholding requirements) shall
be counted when shares of Common Stock are used as full or partial payment for shares issued upon exercise of a Option. Shares
tendered by a Participant as payment for shares issued upon such exercise shall be available for reissuance under the Plan.”

        5.    Eligibility.   Options
may be granted under Section 6 of the Plan to such Employees, Consultants and Advisory Directors of the Corporation or its
Subsidiaries as may be determined by the Committee. Subject to the limitations and qualifications set forth in this Plan, the
Committee shall also determine the number of Options to be granted, the number of shares subject to each Option grant, the
exercise price or prices of each Option, the vesting and exercise period of each Option, whether an Option may be exercised as to
less than all of the Common Stock subject thereto, and such other terms and conditions of each Option as are consistent with the
provisions of this Plan. 

        6.    Grant
of Options.   Except as provided in Section 18(c), the Committee shall determine the number of shares of Common
Stock to be offered from time to time pursuant to Options granted hereunder and shall grant Options under the Plan. No member of
the Committee shall be eligible to receive Options. The grant of Options shall be evidenced by Option agreements containing such
terms and provisions as are approved by the Committee and executed on behalf of the Corporation by an appropriate officer.

2 

        7.    Time
of Grant of Options.   The date of grant of an Option under the Plan shall be the date on which the Committee
awards the Option or, if the Committee so determines, the date specified by the Committee as the date the award is to be
effective. Notice of the grant shall be given to each Participant to whom an Option is granted promptly after the date of such
grant. 

        8.    Price.   The
exercise price for each share of Common Stock subject to an Option (the “Exercise Price”) granted pursuant to Section 6
of the Plan shall be determined by the Committee at the Date of Grant. 

        9.    Vesting.   Subject
to Section 11 of this Plan, each Option award under the Plan shall vest or be subject to forfeiture in accordance with the
provisions set forth in the applicable Option agreement. The Committee may, but shall not be required to, permit acceleration of
vesting or termination of forfeiture provisions upon any sale of the Corporation or similar transaction. A Participant’s
Option agreement may contain such additional provisions with respect to vesting as the Committee may specify. 

        10.    Exercise.   A
Participant may pay the Exercise Price of the shares of Common Stock as to which an Option is being exercised by the delivery of
(a) cash, (b) check, (c) at the Corporation’s option, by the delivery of shares of Common Stock having a Fair
Market Value on the date immediately preceding the exercise date equal to the Exercise Price and have been held by the Optionee at
least six (6) months prior to the date of exercise, or (d) at the Corporation’s option, any other consideration that the
Corporation determines is consistent with the Plan’s purpose and applicable law. If the shares to be purchased are covered by
an effective registration statement under the Securities Act of 1933, as amended, any Option granted under the Plan may be
exercised by a broker-dealer acting on behalf of an Optionee if (i) the broker-dealer has received from the Optionee or the
Corporation a fully- and duly-endorsed agreement evidencing such Option, together with instructions signed by the Optionee
requesting the Corporation to deliver the shares of Common Stock subject to such Option to the broker-dealer on behalf of the
Optionee and specifying the account into which such shares should be deposited, (ii) adequate provision has been made with
respect to the payment of any withholding taxes due upon such exercise, and (iii) the broker-dealer and the Optionee have
otherwise complied with Section 220.3(e)(4) of Regulation T, 12 CFR Part 220, or any successor provision. 

        11.    [Reserved.]  

        12.    Option
Financing.   Upon the exercise of any Option granted under the Plan, the Corporation may, but shall not be
required to, make financing available to the Participant for the purchase of shares of Common Stock pursuant to such Option on
such terms as the Board or the Committee may specify. 

        13.    Withholding
of Taxes.   The Committee shall make such provisions and take such steps as it may deem necessary or
appropriate for the withholding of any taxes that the Corporation is required by any law or regulation of any governmental
authority to withhold in connection with any Option including, but not limited to, (a) withholding the issuance of all or any
portion of the shares of Common Stock subject to such Option until the Participant reimburses the Corporation for the amount it is
required to withhold with respect to such taxes, (b) withholding any portion of such issuance in an amount sufficient to
reimburse the Corporation for the amount of taxes it is required to withhold, (c) allowing the Participant to deliver Common
Stock as payment for the amount the Corporation is required to withhold for taxes or (d) taking any other action reasonably
required to satisfy the Corporation’s withholding obligation. 

        14.    Conditions
Upon Issuance of Shares.  

        (a)    The
Corporation shall not be obligated to sell or issue any shares upon the exercise of any Option granted under the Plan unless the
issuance and delivery of shares comply with all provisions of applicable federal and state securities laws and the requirements of
the New York Stock Exchange or any stock exchange upon which shares of the Common Stock may then be listed. 

3 

        (b)    As
a condition to the exercise of an Option, the Corporation may require the person exercising the Option to make such
representations and warranties as may be necessary to assure the availability of an exemption from the registration requirements
of applicable federal and state securities laws. 

        (c)    The
Corporation shall not be liable for refusing to sell or issue any shares covered by any Option if the Corporation cannot obtain
authority from the appropriate regulatory bodies deemed by the Corporation to be necessary to sell or issue such shares in
compliance with all applicable federal and state securities laws and the requirements of the New York Stock Exchange or any stock
exchange upon which shares of the Common Stock may then be listed. In addition, the Corporation shall have no obligation to any
Participant, express or implied, to list, register or otherwise qualify the shares of Common Stock covered by any Option.

        (d)    No
Participant will be, or will be deemed to be, a holder of any Common Stock subject to an Option unless and until such Participant
has exercised his or her Option and paid the purchase price for the subject shares of Common Stock. 

        15.    Restrictions
on Transfer.  

        (a)    Options
issued pursuant to the Plan shall be nontransferable except by will or the laws of descent and distribution, and may only be
exercisable during the Participant’s lifetime only by the Participant. 

        (b)    Shares
of Common Stock issued pursuant to the Plan may be subject to restrictions on transfer under applicable federal and state
securities laws. The Committee may impose such additional restrictions on the ownership and transfer of shares of Common Stock
issued pursuant to the Plan as it deems desirable; any such restrictions shall be set forth in any Option agreement entered into
hereunder. 

        16.    Modification
of Plan and Options.  

        (a)    The
Committee may from time to time and at any time alter, amend, suspend, discontinue or terminate this Plan. 

        (b)    At
any time and from time to time, the Committee may execute an instrument providing for modification, extension or renewal of any
outstanding Option, provided that no such modification, extension or renewal shall impair the Option without the consent of the
holder of the Option or conflict with the provisions of Rule 16b-3 or the New York Stock Exchange or any stock exchange on which
shares of Common Stock may then be listed. 

        17.    Effect
of Change in Stock Subject to the Plan.   In the event that each of the outstanding shares of Common Stock
(other than shares held by dissenting shareholders) shall be changed into or exchanged for a different number or kind of shares of
stock of the Corporation or of another corporation (whether by reason of merger, consolidation, recapitalization,
reclassification, split-up, combination of shares or otherwise), or in the event a stock split or stock dividend occurs, then the
Corporation may either (a) substitute for each share of Common Stock then subject to Options or available for Options the
number and kind of shares of stock into which each outstanding share of Common Stock (other than shares held by dissenting
shareholders) shall be so changed or exchanged, or the number of shares of Common Stock as is equitably required in the event of a
stock split or stock dividend, together with an appropriate adjustment of the Exercise Price, or (b) cancel all such Options
as of the effective date of any merger, consolidation, recapitalization, reclassification, split-up or combination of shares by
giving written notice to each holder thereof or his personal representatives of its intention to do so and by permitting the
exercise of all such Options, without regard to determinations of periods or installments of exercisability during the thirty (30)
day period immediately preceding such effective date. The Committee may, but shall not be required to, provide additional
anti-dilution protection to a Participant under the terms of the Participant’s Option agreement. 

4 

        18.    Administration.  

        (a)    Notwithstanding
anything to the contrary herein, to the extent necessary to comply with the requirements of Rule 16b-3, the Plan shall be
administered by the Board, or by a committee comprised solely of two or more Non-Employee Directors appointed by the Board (the
group responsible for administering the Plan is referred to as the “Committee”). Options may be granted under Section 6
only by majority agreement of the members of the Committee. Option agreements, in the form as approved by the Committee, and
containing such terms and conditions consistent with the provisions of this Plan as are determined by the Committee, may be
executed on behalf of the Corporation by the Chairman of the Board, the President or any Vice President of the Corporation. The
Committee shall have complete authority to construe, interpret and administer the provisions of this Plan and the provisions of
the Option agreements granted hereunder; to prescribe, amend and rescind rules and regulations pertaining to this Plan; to
suspend, discontinue or terminate this Plan; and to make all other determinations necessary or deemed advisable in the
administration of the Plan. The determinations, interpretations and constructions made by the Committee shall be final and
conclusive. No member of the Committee shall be liable for any action taken, or failed to be taken, made in good faith relating to
the Plan or any award thereunder, and the members of the Committee shall be entitled to indemnification and reimbursement by the
Corporation in respect of any claim, loss, damage or expense (including attorneys’ fees) arising therefrom to the fullest
extent permitted by law. 

        (b)    Members
of the Committee shall be specified by the Board, and if the Committee does not consist of the entire Board, the Committee shall
consist solely of Non-Employee Directors. Non-Employee Directors may not possess an interest in any transaction for which
disclosure is required under Section 404(a) of Regulation S-K under the Exchange Act or be engaged in a business relationship that
must be disclosed under Section 404(a). 

        19.    Continued
Employment Not Presumed.   Nothing in this Plan or any document describing it nor the grant of any Option shall
give any Participant the right to continue in the employment or in the role of Advisory Director or Consultant of the Corporation
or affect the right of the Corporation to terminate the employment, engagement or designation of any such person with or without
cause. 

        20.    [Reserved].  

        21.    Governing
Law.   The Plan shall be governed by and construed in accordance with the laws of State of Minnesota and the
United States, as applicable, without reference to the conflict of laws provisions thereof. 

        22.    Severability
of Provisions.   If any provision of this Plan is determined to be invalid, illegal or unenforceable, such
invalidity, illegality or unenforceability shall not affect the remaining provisions of the Plan, but such invalid, illegal or
unenforceable provision shall be fully severable, and the Plan shall be construed and enforced as if such provision had never been
inserted herein. 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}]]